For US Residents Only
View Health Care Professional Site
Faced with an undiagnosed kidney mass,
Early answers
bring CONFIDENCE
A new, noninvasive way to identify ccRCC
Faced with an undiagnosed kidney mass,
Early answers
bring CONFIDENCE
A new, noninvasive way to identify ccRCC
Could my kidney
mass be cancer?
The most common type of kidney cancer is clear cell renal cell carcinoma (ccRCC), but your mass may be benign or a different type of cancer.1
When ccRCC is detected early, treatment success improves.2
How is ccRCC characterized and staged?
Find OUT >
How is early
ccRCC treated?
know your options >
How might ccRCC be characterized in the future?
A new, noninvasive way to identify ccRCC may soon be available and could make earlier diagnosis possible for more people. This information can also help you and your doctor decide on a treatment plan together.3
LEARN ABOUT CAIX-PET SCANSHelpful resources are available
GET MORE INFONo matter where you are on your journey, Telix Pharmaceuticals is committed to helping people with kidney masses by researching new ways to identify and treat ccRCC.
CAIX, carbonic anhydrase IX; PET, positron emission tomography.
References: 1. National Cancer Institute. Clear cell renal cell carcinoma. Published March 17, 2020. Accessed July 11, 2024. https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-kidney-tumors/clear-cell-renal-cell-carcinoma 2. Cleveland Clinic. Renal cell carcinoma. Accessed July 11, 2024. https://my.clevelandclinic.org/health/diseases/24906-renal-cell-carcinoma 3. Hekman MCH, Rijpkema M, Aarntzen EH, et al. Positron emission tomography/computed tomography with 89Zr-girentuximab can aid in diagnostic dilemmas of clear cell renal cell carcinoma suspicion. Eur Urol. 2018;74(3):257-260.